Skip to main content

Neoadjuvant carboplatin and weekly paclitaxel for stage Ib-IIIa non-small cell lung cancer (NSCLC): A Brown University Oncology Group (BrUOG) phase II study

Publication ,  Conference
Ng, T; Berz, D; Birnbaum, A; Dipetrillo, TA; Henderson, D; Kennedy, T; Ready, NE
Published in: Journal of Clinical Oncology
May 20, 2008

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2008

Volume

26

Issue

15_suppl

Start / End Page

18502 / 18502

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ng, T., Berz, D., Birnbaum, A., Dipetrillo, T. A., Henderson, D., Kennedy, T., & Ready, N. E. (2008). Neoadjuvant carboplatin and weekly paclitaxel for stage Ib-IIIa non-small cell lung cancer (NSCLC): A Brown University Oncology Group (BrUOG) phase II study. In Journal of Clinical Oncology (Vol. 26, pp. 18502–18502). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2008.26.15_suppl.18502
Ng, T., D. Berz, A. Birnbaum, T. A. Dipetrillo, D. Henderson, T. Kennedy, and N. E. Ready. “Neoadjuvant carboplatin and weekly paclitaxel for stage Ib-IIIa non-small cell lung cancer (NSCLC): A Brown University Oncology Group (BrUOG) phase II study.” In Journal of Clinical Oncology, 26:18502–18502. American Society of Clinical Oncology (ASCO), 2008. https://doi.org/10.1200/jco.2008.26.15_suppl.18502.
Ng T, Berz D, Birnbaum A, Dipetrillo TA, Henderson D, Kennedy T, et al. Neoadjuvant carboplatin and weekly paclitaxel for stage Ib-IIIa non-small cell lung cancer (NSCLC): A Brown University Oncology Group (BrUOG) phase II study. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008. p. 18502–18502.
Ng, T., et al. “Neoadjuvant carboplatin and weekly paclitaxel for stage Ib-IIIa non-small cell lung cancer (NSCLC): A Brown University Oncology Group (BrUOG) phase II study.” Journal of Clinical Oncology, vol. 26, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2008, pp. 18502–18502. Crossref, doi:10.1200/jco.2008.26.15_suppl.18502.
Ng T, Berz D, Birnbaum A, Dipetrillo TA, Henderson D, Kennedy T, Ready NE. Neoadjuvant carboplatin and weekly paclitaxel for stage Ib-IIIa non-small cell lung cancer (NSCLC): A Brown University Oncology Group (BrUOG) phase II study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008. p. 18502–18502.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2008

Volume

26

Issue

15_suppl

Start / End Page

18502 / 18502

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences